Enhancing Breast Cancer Detection with AI: Insights from Dr. Rachel Brem

Dr. Rachel Brem, from a young age, decided to dedicate her life to curing cancer after her mother was diagnosed with breast cancer. Early detection played a crucial role in her mother’s extended survival. Brem now focuses on enhancing breast cancer screening for all women, holding the position of Director of Breast Imaging and Intervention at George Washington University. She founded the Brem Foundation to combat breast cancer through prevention and early detection.

Impact of Artificial Intelligence on Breast Imaging

Brem believes AI is transforming medicine, particularly breast cancer detection. She collaborates with ScreenPoint Medical to develop Transpara, an AI software for breast cancer screening. Research indicates mammograms combined with AI evaluations can find cancer up to five years earlier than traditional methods, identifying warning signs possibly missed otherwise. Brem highlights how AI-enhanced mammograms can predict future breast cancer risk, even when no cancer is visible.

Women who begin screenings at age 35 with AI-enhanced readings might benefit from AI’s ability to improve continuously. Brem mentioned that at George Washington University, AI has been used in mammograms for over four years without additional costs for patients. However, across the nation, only 20% of practices incorporate AI, often due to extra costs.

Addressing Inequities in Cancer Detection

Brem acknowledged the challenge of eradicating breast cancer entirely, but emphasized the potential of AI to ameliorate disparities in diagnosis and treatment. For instance, Black women experience breast cancer mortality at a 40% higher rate compared to White women. Additionally, women with fewer resources struggle with access to mammograms. Brem’s foundation has fought for equitable access, innovative screening, and increased awareness for two decades.

Developing a Noninvasive Breast Cancer Breath Test

Brem is also involved in developing a breath test for breast cancer detection. Diseased tissues release chemical compounds as gas, offering a noninvasive screening method. Although not yet available, Brem is optimistic about this painless diagnostic approach, which could extend beyond breast cancer to create a comprehensive women’s health panel through a single breath analysis.

Current Breast Cancer Screening Recommendations

The American College of Physicians guides women over 50 to undergo biennial mammograms. The U.S. Preventive Services Task Force recommends starting at age 40. Brem considers these guidelines insufficient, advocating annual screenings from age 40 and earlier screenings at 35 for those with a family history of breast cancer. Fear often deters women from timely screenings, but Brem stresses the importance of early detection for better outcomes, with a 99% survival rate for early-stage breast cancer.

Importance of Additional Screening for Dense Breasts

Half of all women have dense breasts, where mammograms might not detect tumors. Brem recommends supplemental exams like ultrasounds or MRIs for fuller risk assessment and encourages women to insist on these from their doctors. Mammograms alone may not suffice.

Advocating for Personal Health

Brem urges women, especially those under 40, to demand additional screenings if needed. “You’re not too young to have breast cancer,” she warns. Proactive conversations and planning for cancer screenings are vital for early detection, even for younger women. Brem’s foundation supplies educational resources to empower women. She emphasizes the importance of self-advocacy in healthcare.

“We tell women to be bold,” Brem says. “Advocate for yourself. It’s your right. It’s what you deserve.”